-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Pasithea Therapeutics Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2023 to Q3 2024.
- Pasithea Therapeutics Corp. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $121K, a 18.6% increase year-over-year.
- Pasithea Therapeutics Corp. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $176K.
- Pasithea Therapeutics Corp. annual Share-based Payment Arrangement, Expense for 2023 was $72K.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)